US Stocks
/
CytomX Therapeutics, Inc. Share Price
CytomX Therapeutics, Inc. Share Price

CytomX Therapeutics, Inc. Share Price

NASDAQ: CTMX | Small Cap
$2.46
-$0.10 (-3.72%) Last updated on 09 Oct, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

CytomX Therapeutics, Inc. Stock Performance

Open
$2.51
Prev. Close
$2.56
Circuit Range
N/A
Day Range
$2.44 - $2.51
Year Range
$2.44 - $8.20
Volume
2,54,097
Average Traded
$2.46

CytomX Therapeutics, Inc. Share Price Today

As of 9 October 2026, CytomX Therapeutics, Inc.'s share price is $2.46. The stock opened at $2.51, compared to its previous close of $2.56. During today's trading session, CytomX Therapeutics, Inc.'s share price traded between $2.44 and $2.51, with an average price of $2.47. Over the past 52 weeks, the stock has recorded a high of $8.20 and a low of $2.44. In terms of performance, CytomX Therapeutics, Inc.'s share price has declined by 41.64% over the last six months and is down 31.19% on a year-on-year basis.

CytomX Therapeutics, Inc. Share Price Chart

$2.44$2.51
L
Show Current Price
H

CytomX Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$339.32M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.38
Revenue (TTM)
$76.20B
Return On Equity (TTM)
-27.36%
Profit Margin
-26.73%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-45.26%

CytomX Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$5.96$0.66$10.26$1.42
Net Profit-$14.23-$29.51-$18.25-$20.67
Net Profit Margin-238.76%-4471.21%-177.88%-1455.63%
Income ChangeN/A-107.38%38.16%-13.26%

CytomX Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$53.16$101.21$138.10$76.20
Net Profit-$99.32-$0.57$31.87-$20.37
Net Profit Margin-186.83%-0.56%23.08%-26.73%
Income ChangeN/A99.43%5691.23%-163.92%

About CytomX Therapeutics, Inc.

CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.

CytomX Therapeutics, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$2.69
$2.48
-8.84%
Sep 2026
$3.35
$2.71
-20.61%
Aug 2026
$3.09
$3.42
+10.32%
Jul 2026
$3.78
$3.10
-17.33%
Jun 2026
$3.58
$3.75
+4.46%
May 2026
$4.25
$3.59
-14.83%
Apr 2026
$4.73
$4.21
-10.32%
Mar 2026
$5.29
$4.70
-12.23%
Feb 2026
$5.63
$5.36
-6.05%
Jan 2026
$4.27
$5.70
+33.18%
Dec 2025
$4.13
$4.28
+0.23%
Nov 2025
$3.60
$4.27
+19.44%

CTMX Share Price FAQs

What is CytomX Therapeutics, Inc. share price today?

chevron-up
CytomX Therapeutics, Inc. share price today is $2.46 as on October 9, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of CytomX Therapeutics, Inc. stock?

chevron-up
The 52 week high of CytomX Therapeutics, Inc. stock is $8.20, while the 52 week low is $2.44 as of 9 Oct '26.

What is CTMX's market capitalisation today?

chevron-up
CTMX market capitalisation is $339.32M as of October 9, 2026, at 6:10 pm IST.

What is CTMX's net income for the last quarter?

chevron-up
CTMX's net income for the last quarter is -20.67B USD.

What is the 5 year returns of CTMX?

chevron-up
The 5 year returns of CTMX is -58.52% as on 9 Oct '26.

What is the high & low stock price of CTMX today?

chevron-up
CTMX stock price hit a high of $2.51 and low of $2.44 as of 9 Oct '26.

Can I buy CTMX shares in India?

chevron-up
Yes. You can buy CTMX in India by opening an international trading account.